Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-05-01GLUE144Warmuth Markus plan to sell securities of Monte Rosa Therapeutics, Inc. under Form 144MEDIUM
Warmuth Markus filed Form 144 to notify SEC of plan to sell 5467 units of Monte Rosa Therapeutics, Inc. securities around 2026-05-01, with aggregate market value of $103,446,628.00. The total outstanding units is 84382573.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transactions ...
Small CapBiotechnology
2026-05-01NRIX144CHRISTINE RING plan to sell securities of NURIX THERAPEUTICS INC under Form 144MEDIUM
CHRISTINE RING filed Form 144 to notify SEC of plan to sell 5394 units of NURIX THERAPEUTICS INC securities around 2026-05-01, with aggregate market value of $90,079.80. The total outstanding units is 103405813.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transactions in past 3 m...
Small CapBiotechnology